Israel · Medical and donor conditions

A blank consent-review folder and pen on a desk, with an unbranded microscope visible through glass in a clinical laboratory.
Editorial illustration only; it does not depict a real clinic, person, authority or verified facility.

Israel surrogacy: medical screening and donor-gamete rules

Israel surrogacy medical rules: the approval committee gate, surrogate screening, Ministry of Health medical flags, donor eggs and sperm, parents' evidence.

The short answer: identify which kind of rule applies

Israel’s surrogacy process has several rule layers. The Embryo Carrying Agreements Law (Agreement Approval and Status of the Newborn), 5756-1996, governs agreement approval. The Ministry of Health’s service page explains committee conditions and required documents; a separate medical guideline lists health factors used to screen surrogate candidates. Hospital IVF units may also require treatment-specific tests. A statutory condition, administrative checklist and clinical risk factor have different legal status; a risk flag is not automatically an absolute statutory ban.

This guide covers medical evidence and gamete sourcing, not every issue of intended-parent eligibility, contract terms, parentage, citizenship or cross-border recognition. The Ministry says the law prevails over conflicting web summaries. Before treatment, check the current Hebrew law and committee forms and obtain written confirmation from the responsible Israeli authority.

The approval committee’s legal gate

A surrogacy agreement must be approved by the statutory Approval Committee; a clinic’s willingness to perform IVF is not enough. The Ministry’s legal summary says the committee must confirm voluntary informed consent, understanding of the agreement’s meaning and consequences, no apparent danger to the surrogate’s health or the future child’s welfare, and no improper prejudice to the rights of the parties or child.

The agreement may allow no more than six attempts to implant fertilized ova. IVF, transfer, pregnancy and birth must take place in Israel unless the committee authorizes part of the pregnancy abroad for justified reasons and on set conditions. Material changes before embryo transfer must be reported promptly; the committee may reconsider approval before implantation.

The surrogate candidate: baseline screening conditions

The Ministry’s current published criteria say the surrogate must be an Israeli resident and, when the agreement is approved, at least 22 but under 39. She must previously have been pregnant and given birth other than as a surrogate, and her children must not have been removed from her custody under law. She must not be related to either intended parent. The Ministry also states that a married candidate is normally not approved unless the committee is satisfied that reasonable efforts to find an unmarried candidate failed and the spouse has been informed and heard. The service page measures age at agreement approval, while the medical guideline also refers to age at document submission and agreement signing; if the candidate is approaching 39, obtain written confirmation of the applicable checkpoint.

The updated medical guideline describes up to three surrogacy procedures, but says a third is not approved if the two earlier procedures ended in (1) a birth in each procedure; (2) a birth in one and exhaustion of six embryo transfers in the other; or (3) exhaustion of six transfers in each. The English service page gives a shorter summary; the current Hebrew service page lists the same three outcome-based scenarios as the detailed guideline, so this is a difference in detail rather than a confirmed substantive contradiction. Disclose every prior arrangement, birth and transfer outcome and obtain written confirmation of how the committee counts them. The candidate should have no more than four prior childbirths, with a normal obstetric history and no significant pregnancy or delivery complications. At the complete-application stage, at least 12 months should have passed after a vaginal birth and at least 18 months after a caesarean birth. The candidate’s partner must complete the required tests as well.

The Ministry also says previous births should have been full-term and uncomplicated, with newborns of normal birth weight for gestational age, and all required tests for the candidate and her partner should be normal. The current Hebrew service page says testing and document collection may begin no earlier than 11 months after a vaginal birth or 17 months after a caesarean; the current English service page gives 11 months after vaginal birth but 15 months after caesarean. This discrepancy remains unresolved. Obtain written confirmation from the national supervisor before relying on the earlier 15-month start.

Medical factors the Ministry guideline flags

The Ministry’s medical guideline, updated 7 December 2025, has a section headed “Situations in which a candidate will not be approved.” It lists no previous birth or five or more births; two or more caesarean deliveries; a most recent birth before 35 weeks or a newborn with intrauterine growth restriction (IUGR); an obstetric anal-sphincter tear classified as grade 3B or higher (a grade 3A tear is assessed individually); and an ectopic pregnancy. It also flags surgery that could affect health or a future pregnancy (individual review), bariatric surgery (if a birth occurred after it, individual review), miscarriage associated with a risk of cervical insufficiency, and stillbirth; the guideline expressly calls for individual assessment of several of these situations.

The Ministry’s earlier March 2024 medical-screening PDF also listed a family history of type 2 diabetes in the candidate’s parents together with an abnormal 75-g oral glucose-tolerance test; gestational diabetes or hypertension in one or more pregnancies; current or past hypertension; pre-eclampsia in a second or later pregnancy (a first-pregnancy case is assessed individually); genital herpes, condyloma/acuminata or HPV; abnormal cervical-cell changes; cervical conization; a close family history of breast or ovarian cancer or a BRCA mutation; Rh-negative blood with a positive Coombs test; tobacco, drug or alcohol use; certain personality or mental-health disorders, psychiatric hospitalization or current psychiatric treatment; depression before or after childbirth; and inability to give informed consent. It also listed chronic disease that could endanger the surrogate or fetus. Treat the additional details from the earlier PDF as a historical screening reference, not proof that every item remains unchanged or has the same status today; confirm the current list and individual-review rules with the committee before relying on it. The guideline also requires infection screening for the surrogate’s partner.

A medical flag is not always a categorical statutory ban

The 2025 Ministry guideline says the committee may assess each case individually and is not bound by its recommendations. Treat the list as an official screening framework, not as the statute or a guarantee of a uniform outcome. Some factors are listed as grounds for non-approval; others are expressly left to individual review.

Disclose diagnoses, pregnancy outcomes, surgery, medication, smoking and psychiatric treatment. Ask the treating specialist to describe the current risk in writing and the committee whether the factor is a categorical exclusion or can be assessed individually. The statutory approval test still includes risk to the surrogate’s health and the child’s welfare, plus the other legal conditions.

Medical evidence from the intended parents

For an intended mother, the Ministry requires an obstetrician-gynaecologist or relevant specialist’s opinion explaining why she cannot conceive and carry a pregnancy, or why pregnancy could significantly endanger her health. A family-physician medical summary is also required. If there is an underlying condition, the current application instructions call for an additional opinion from the relevant treating specialist. The committee considers the intended parents’ health when assessing suitability; a complete file does not guarantee approval.

For an intended father, the published checklist calls for a family-physician opinion, a statement identifying the source of the egg to be fertilized, a recent semen analysis performed at a recognized institute where his sperm will be used, and screening for HIV, hepatitis B/C and syphilis (VDRL). An individual intended mother’s checklist additionally asks for proof of the sperm source, confirmation that the egg is her own, blood type, HIV, hepatitis and syphilis screening; the Ministry says donated eggs cannot be used in that individual-mother route. The English service page abbreviates the hepatitis test inconsistently as “HbSAg”; obtain the current laboratory list rather than assume one marker covers both viruses.

Genetic connection, egg age and donor combinations

At least one gamete used for IVF must come from an intended parent. The Ministry says an intended mother’s eggs or donor eggs may be used only where the eggs were retrieved before she turned 43; the relevant age is the age at retrieval, not the age when the agreement is signed. The committee’s page says it will not approve use of eggs retrieved after that threshold. A surrogate’s own eggs may not be used: the Israeli process is gestational surrogacy, not a route for the carrier to provide the egg.

The Ministry’s egg-donation guidance expressly says that, in a surrogacy arrangement, donor eggs are available only when the intended parents are a man and a woman who are partners; donor eggs cannot be combined with donor sperm in the same surrogacy process. Although the separate surrogacy page recognizes an individual intended father, that general eligibility statement does not override the specific gamete restriction. The published guidance does not establish an approved donor-egg route for a single man or a male couple, and it does not state that importing eggs creates an exception. Before paying for eggs, creating embryos or arranging shipment, obtain written confirmation from the national surrogacy supervisor and the recognized Israeli IVF unit for the exact intended parents, donor material and proposed route.

For two male intended parents (or two intended parents with male gametes), the Ministry says the sperm must come from one of them. Sperm from both must not be mixed in the same fertilization, and embryos from both fathers must not be transferred in the same treatment cycle. If separate cycles use eggs fertilized with each father’s sperm, the surrogate must consent in advance in the agreement.

Egg donors: eligibility, health checks and consent

For an egg donation carried out in Israel, the Ministry’s donor guidance lists an Israeli-resident donor aged 21–35. The donor must not be legally incapacitated, under guardianship, detained or imprisoned. As a rule, she must not be related to the recipient or the intended genetic father; where sperm donation is involved, the guidance also addresses a relationship between the egg donor and sperm donor. Donor and recipient normally must share a religion, and a volunteer donor is normally unmarried. A donor may undergo up to three donation cycles, with at least 180 days between them.

These are not all unwaivable rules: the Ministry describes an exceptional-cases committee that can approve specified departures, including some cases involving a different religion, a married donor, or a known/related donor. The donor must receive an explanation of the procedure and its risks, undergo physical and laboratory testing and a psychological assessment, and obtain approval from the hospital’s egg-donation committee. That committee checks that consent is informed, clear and voluntary, without family, social, financial or other pressure. For eggs from abroad, do not assume every domestic eligibility detail applies in the same way; confirm the approved import route and donor-screening protocol in writing.

Sperm donors: screening and the meaning of “preferably”

The Ministry’s sperm-donation page says donors are single men and describes ages 18–30 as preferred, not as a categorical statutory age limit. Selection includes an initial interview and semen testing, including freezing and thawing to assess quality; the sperm bank may reject a sample that does not meet laboratory standards. The bank also reviews personal and family medical history, possible genetic disease, social background, physical health, blood tests and syphilis screening, with further tests where medically indicated.

Use a sperm bank recognized by the Ministry and obtain the current written screening record for the material proposed. Ministry guidance describes donor anonymity and confidentiality in the domestic system, but the practical information available to recipients can depend on the route and source of the sample. The relevant surrogacy rule is not merely whether sperm is medically usable: the proposed combination must also comply with the genetic-link requirement and the restriction on combining donor eggs and donor sperm in a surrogacy arrangement.

Foreign eggs or embryos, and clinic-specific protocols

The Ministry describes a route for receiving egg donations from abroad through IVF units and overseas clinics authorized to work with Israeli units, with the procedure arranged by Israeli physicians or with fertilized eggs brought to Israel through the approved pathway. That does not mean any overseas donor agency, bank or clinic is automatically acceptable. Before paying or shipping material, verify the current recognition/permit, the exact material covered (unfertilized eggs versus embryos), the receiving Israeli unit, documentation, infectious-disease and genetic-screening records, and any current temporary extension or expiry date.

An IVF unit may request carrier screening, additional infection tests, genetic counselling or other tests because of the donor, recipient, family history or proposed treatment. Those requirements may be clinically appropriate, but do not label every clinic protocol as a statutory prohibition. Ask the unit to identify whether each requested item comes from the law, a current Ministry/committee form, an import authorization or its own clinical protocol. Keep the written answer with the application file.

A practical checklist before signing or starting treatment

Before signing the agreement, paying for donor material or beginning ovarian stimulation/IVF, request a dated written checklist from the national committee and the recognized IVF unit. Confirm: (1) the surrogate’s age, residence, previous births, previous surrogacy attempts, obstetric history and time since the last delivery; (2) the exact medical and infectious-disease tests required for her and her partner; (3) the intended parents’ specialist opinions and health summaries; (4) the source of each egg and sperm, the egg-retrieval date and age, and the recent semen analysis if an intended father’s sperm is used; and (5) the donor’s eligibility, screening, consent and records.

Also obtain written confirmation of the six-transfer limit, the permitted gamete combination for these intended parents, and any import approval required for eggs or embryos. Do not pay for or ship donor material until the written response covers the exact material and route.

If the clinic and the committee give different answers

If a clinic says that a medical condition automatically disqualifies a surrogate, compare that statement with the current Ministry guideline and ask whether the guideline allows individual assessment. If a clinic says a treatment is permitted, that does not prove the Approval Committee will approve the agreement or that a donor route complies with the rules. Request the legal or administrative basis in writing and have the Israeli specialist and lawyer review the same version of the documents.

If the committee rejects the application, request the written decision, the factual reasons and the specific rule applied. Ask Israeli counsel promptly whether a review or appeal route exists and what deadline applies; do not assume that a remedy or deadline exists without checking the current rules. Report material changes in the information supplied before embryo transfer. Do not assume that an oral assurance, a donor-agency statement or a technically successful IVF cycle replaces legal approval.

Sources and verification notes

Official Ministry pages were checked directly where accessible; some Hebrew pages and PDFs were available only through official search-index extracts on 23 October 2026. Source S10 is the earlier March 2024 PDF and is used only as a historical cross-check; the current medical list and the individual-review status of each factor require confirmation against the committee’s current version.

  1. [S1] Israel Ministry of Health, “Surrogacy in Israel” (English service page)
  2. [S2] Israel Ministry of Health, “Medical Requirements from a Surrogate Mother Candidate” (Hebrew PDF; updated 7 December 2025)
  3. [S3] Israel Ministry of Health, “Medical Requirements from Intended Parents” (Hebrew PDF; updated January 2023)
  4. [S4] Israel Ministry of Health, “Receive Ova Donations from Israel or Abroad” (English service page)
  5. [S5] Israel Ministry of Health, “Ovum Donation” (Hebrew service page)
  6. [S6] Israel Ministry of Health, “Sperm Donation” (English service page)
  7. [S7] Israel Ministry of Health, “Receiving a Sperm Donation” (English service page)
  8. [S9] Israel Ministry of Health, “Surrogacy in Israel” (current Hebrew service page; cross-check for timing and medical criteria)
  9. [S10] Israel Ministry of Health, earlier “Medical Requirements from a Surrogate Mother Candidate” PDF (March 2024; earlier version) Earlier March 2024 version. Confirm current requirements against the December 2025 guideline.

Last updated:

Author: Khachatrian Razmik, LL.M.

International surrogacy and parentage legal services — LEX SURROGACY by Lex Agency · Author profile · Editorial standards